The Effect of Neuro Linguistic Programming on COVID-19 Fear in Kidney Transplant

Kidney Transplant Patients Clinical Trial

Official title: The Effect of Neuro Linguistic Programming on COVID-19 Fear in Kidney Transplant

Status Completed

Clinical Trial Summary

The study was conducted experimentally to evaluate the effect of neurolinguistic programming on COVID-19 fear in kidney transplant patients.

Clinical Trial Description

The study was conducted experimentally (prospective randomized single-blind clinical trial model) to evaluate the effect of neurolinguistic programming (NLP) on fear of Covid-19 in kidney transplant patients.

The study was carried out between June 2021 and October 2021. Personal Information Form and Fear of COVID-19 Scale (FCV-19S) were used to collect data. The data obtained from the research were evaluated with SPSS 25.

According to the calculation made using G*power 3.1 software, the sample size was determined as 74 (each group 37) with an effect size of 0.80, a margin of error of 0co.05, a confidence level of 0.95, and a population representation of 0.95. Simple random sampling method, one of the probability sampling methods, was used to determine the participants. Single-group columns between 1 and 300 were created using the Random Integer Generator method, which located in the Numbers sub-heading of the random.org website for the participants who met the sample selection criteria. Participants were randomly assigned to numbers 1 and 2, considering the numbers 1 and 2 in the column. The number of the experimental or control group was determined by drawing lots at the beginning of the research ;

Related Conditions & MeSH terms

• COVID-19
• Kidney Transplant Patients

• NCT number: NCT05115435
• Study type: Interventional
• Source: Inonu University
• Status: Completed
• Phase: N/A
• Start date: March 1, 2021
• Completion date: November 1, 2021